 Altamira Therapeutics Ltd NASDAQ: CYTO shares are trading higher Monday after the company announced a peer-reviewed publication on positive in vitro data with its Bentrio drug-free nasal spray against the SARS-CoV-2 delta variant. The International Journal of Molecular Sciences . 